Correction: LncRNA MALAT1 promotes growth and metastasis of head and neck squamous cell carcinoma by repressing VHL through a non-canonical function of EZH2

被引:0
|
作者
Yuansheng Duan
Kai Yue
Beibei Ye
Peng Chen
Jin Zhang
Qinghua He
Yue Wu
Qingchuan Lai
Hong Li
Yansheng Wu
Chao Jing
Xudong Wang
机构
[1] Tianjin’s Clinical Research Center for Cancer,Department of Maxillofacial and Otorhinolaryngological Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and T
[2] Tianjin Medical University Cancer Institute and Hospital,Department of Bone and Soft Tissue Tumors
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] HBx-upregulated lncRNA UCA1 promotes cell growth and tumorigenesis by recruiting EZH2 and repressing p27Kip1/CDK2 signaling
    Jiao-Jiao Hu
    Wei Song
    Shao-Dan Zhang
    Xiao-Hui Shen
    Xue-Mei Qiu
    Hua-Zhang Wu
    Pi-Hai Gong
    Sen Lu
    Zhu-Jiang Zhao
    Ming-Liang He
    Hong Fan
    Scientific Reports, 6
  • [32] HBx-upregulated lncRNA UCA1 promotes cell growth and tumorigenesis by recruiting EZH2 and repressing p27Kip1/CDK2 signaling
    Hu, Jiao-Jiao
    Song, Wei
    Zhang, Shao-Dan
    Shen, Xiao-Hui
    Qiu, Xue-Mei
    Wu, Hua-Zhang
    Gong, Pi-Hai
    Lu, Sen
    Zhao, Zhu-Jiang
    He, Ming-Liang
    Fan, Hong
    SCIENTIFIC REPORTS, 2016, 6
  • [33] PINCH-1 promotes tumor growth and metastasis by enhancing DRP1-mediated mitochondrial fission in head and neck squamous cell carcinoma
    Tian, Ruxian
    Song, Hao
    Li, Jiaxuan
    Yuan, Ting
    Liu, Jiahui
    Wang, Yaqi
    Li, Yumei
    Song, Xicheng
    CANCER BIOLOGY & THERAPY, 2025, 26 (01)
  • [34] Long noncoding RNA FALEC inhibits proliferation and metastasis of tongue squamous cell carcinoma by epigenetically silencing ECM1 through EZH2
    Jia, Bo
    Xie, Tao
    Qiu, Xiaoling
    Sun, Xiang
    Chen, Jun
    Huang, Zhijie
    Zheng, Xianghuai
    Wang, Zhiping
    Zhao, Jianjiang
    AGING-US, 2019, 11 (14): : 4990 - 5007
  • [35] ETS1 Promotes Aerobic Glycolysis and Growth in Head and Neck Squamous Cell Carcinoma by Targeting RRAS2
    Liu, Jianguo
    Wang, Zhi
    Tian, Xiaoyan
    Xie, Bingbin
    Liu, Ke
    BIOCHEMICAL GENETICS, 2024,
  • [36] STC2 promotes head and neck squamous cell carcinoma metastasis through modulating the PI3K/AKT/Snail signaling
    Yang, Shuwen
    Ji, Qinghai
    Chang, Bin
    Wang, Yan
    Zhu, Yongxue
    Li, Duanshu
    Huang, Caiping
    Wang, Yulong
    Sun, Guohua
    Zhang, Ling
    Guan, Qing
    Xiang, Jun
    Wei, Wenjun
    Lu, Zhongwu
    Liao, Tian
    Meng, Jiao
    Wang, Ziliang
    Ma, Ben
    Zhou, Li
    Wang, Yu
    Yang, Gong
    ONCOTARGET, 2017, 8 (04) : 5976 - 5991
  • [37] Tazemetostat, a selective EZH2 inhibitor, with pembrolizumab as treatment of anti-PD-1 resistant head and neck squamous-cell carcinoma (HNSCC): A phase 1-2 trial.
    Puram, Sidharth
    Oppelt, Peter John
    Ley, Jessica C.
    Cohen, Jared
    Alberti, Justin
    Shannon, Erik
    Liu, Jingxia
    Adkins, Douglas
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [38] Overexpression of ZEB2-AS1 promotes epithelial-to-mesenchymal transition and metastasis by stabilizing ZEB2 mRNA in head neck squamous cell carcinoma
    Diao, Pengfei
    Ge, Han
    Song, Yue
    Wu, Yaping
    Li, Jin
    Li, Zhongwu
    Yang, Jianrong
    Wang, Yanling
    Cheng, Jie
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2019, 23 (06) : 4269 - 4280
  • [39] LncRNA RASAL2-AS1 promotes METTL14-mediated m6A methylation in the proliferation and progression of head and neck squamous cell carcinoma
    Rong, Meiting
    Zhang, Ming
    Dong, Feihong
    Wu, Ke
    Cai, Bingkun
    Niu, Jinrui
    Yang, Le
    Li, Zhongyan
    Lu, Hui-yi
    CANCER CELL INTERNATIONAL, 2024, 24 (01)
  • [40] LncRNA RASAL2-AS1 promotes METTL14-mediated m6A methylation in the proliferation and progression of head and neck squamous cell carcinoma
    Meiting Rong
    Ming Zhang
    Feihong Dong
    Ke Wu
    Bingkun Cai
    Jinrui Niu
    Le Yang
    Zhongyan Li
    Hui-yi Lu
    Cancer Cell International, 24